Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02265224Phase 1Completed
Phase 1, randomised, open-label trial of acetylcysteine in mucus hypersecretion (2 arms), sponsored by Zambon. Primary endpoints: Maximum Plasma Concentration and Area Under the Curve from time 0 to last measurable concentration. Started Sep 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02265224.